![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
(51) | INT.CL. | C07C 229/38 | |
C07C 317/22 | |||
C07C 63/04 | |||
C07C 257/00 | |||
C07D 333/22 | |||
C07D 307/02 | |||
C07D 277/30 | |||
C07D 207/30 | |||
C07D 207/08 | |||
C07D 211/70 | |||
C07D 311/78 | |||
A61K 31/192 | |||
A61K 31/341 | |||
A61P 7/00 |
(11) | Patento numeris | 1383731 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 01981772.5 |
Europos patento paraiškos padavimo data | 2001-10-22 | |
(97) | Europos patento paraiškos paskelbimo data | 2004-01-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2009-08-05 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2001/032582 |
Data | 2001-10-22 |
(87) | Numeris | WO 2002/034711 |
Data | 2002-05-02 |
(30) | Numeris | Data | Šalis |
281735 P | 2001-04-06 | US |
(72) |
BABU, Yarlagadda, S., US
ROWLAND, Scott, R., US
CHAND, Pooran, US
KOTIAN, Pravin, L., US
EL-KATTAN, Yahya, US
NIWAS, Shri, US
|
(73) |
BIOCRYST PHARMACEUTICALS, INC.,
2910 Parkway Lake Drive, Birmingham, Alabama 35244,
US
|
(54) | BIARYL COMPOUNDS AS SERINE PROTEASE INHIBITORS |
BIARYL COMPOUNDS AS SERINE PROTEASE INHIBITORS |